Common use of Biosimilar Clause in Contracts

Biosimilar. Following the first commercial sale of a Biosimilar in a country and: (i) such Biosimilar is Covered by a Valid Claim [***] Covering the Immunocore Product License Agreement relating to MAGE-A4 and [***] compounds 20 in such country, and [***], no royalty reduction may be made under this Section 6.4.3(b); (ii) such Biosimilar is Covered by a Valid Claim [***] in such country, [***], the royalties due and payable by Immunocore hereunder shall be reduced by [***] in such country; (iii) such Biosimilar is Covered by a Valid Claim in such country, [***], and where [***], the royalties due and payable by Immunocore hereunder shall be reduced by [***] in such country; or (iv) such Biosimilar is not Covered by a Valid Claim in such country, the royalties due and payable by Immunocore or its Sublicensee hereunder shall be reduced by [***] in such country [***].